Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Deciphera Pharmaceuticals …

Zogenix (ZGNX) is one of the pharma’s biggest losers today. The reason?

With primary care clinicians playing an ever-increasing role in the management of diabetes, staying on top of new developments in the American Diabetes …

In one of the largest investments to date by a single investor in a publicly traded cannabis company, MedMen (MMNFF) announced this morning that …

It’s a short and dramatic plunge for Biogen (BIIB) stock. Today, the biotech giant’s shares lost 29% of their value and reached levels …

There’s little doubt that the burgeoning pot industry offers plenty of opportunity for investors. According to a report by BDS Analytics, global consumer cannabis …

It’s a very rewarding trading day for investors in Spark Therapeutics (ONCE) with shares skyrocketing 120%, making the stock Wall Street’s bull of …

You know there was some bad news with a company’s quarterly update when the stock tanks after the results are announced. That’s what …

With Intercept (ICPT) preparing to release Phase 3 results from its REGENERATE study in Non-Alcoholic Steatohepatitis (NASH) patients, Gilead (GILD) announced yesterday that its top late-stage NASH drug …

It’s a very rewarding trading day for investors in MacroGenics (MGNX) with shares up over 120%, making the stock Wall Street’s bull of …